fac-Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III)
- $496.19 - $753
- Product name: fac-Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III)
- CAS: 405289-74-9
- MF: C39H24IrN3S3
- MW: 823.058
- EINECS:
- MDL Number:MFCD09842732
- Synonyms:fac-Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III);fac-Ir(btpy)3, Tris(2-(benzo[b]thiophen-2-yl)pyridineiridium(III);Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III);FAC-IR(BTPY)3;Tris(2-(benzo[b]thiophen-2-yl)pyridineiridium(III);Ir(btpy)3;Ir(btpy)3 , fac-Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N;IridiuM,tris[2-(2-pyridinyl-kN)benzo[b]thien-3-yl-kC]-
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 250mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberOGM0000582
- Product descriptionTRIS[2-(BENZO[B]THIOPHEN-2-YL)PYRIDINATO-C3,N]IRIDIUM(III) 95.00%
- Packaging5MG
- Price$496.19
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number680877
- Product descriptionTris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III) 96%
- Packaging250mg
- Price$753
- Updated2022-05-15
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | OGM0000582 | TRIS[2-(BENZO[B]THIOPHEN-2-YL)PYRIDINATO-C3,N]IRIDIUM(III) 95.00% | 5MG | $496.19 | 2021-12-16 | Buy |
Sigma-Aldrich | 680877 | Tris[2-(benzo[b]thiophen-2-yl)pyridinato-C3,N]iridium(III) 96% | 250mg | $753 | 2022-05-15 | Buy |
Properties
Melting point :>300 °C
CAS DataBase Reference :405289-74-9
color :Red powder
Absorption :λmax?292, 366, 408 nm?in THF
CAS DataBase Reference :405289-74-9
color :Red powder
Absorption :λmax?292, 366, 408 nm?in THF
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|